14 results on '"van Melick, H."'
Search Results
2. PO-1389 Interrater agreement in contouring the neurovascular bundle and internal pudendal artery for MRgRT
3. PO-1375 Feasibility of neurovascular sparing MR-guided adaptive radiotherapy for prostate cancer
4. PT206 - Validation of Gallium-68 PSMA-PET/CT for primary lymph node staging in prostate cancer patients
5. 624 - The FUTURE trial: A RCT on MRI targeted prostate biopsy. Comparison of targeted and systematic biopsy outcomes
6. 541 - Follow-up in active surveillance for prostate cancer: Variety in Dutch practice patterns
7. 536 - Active surveillance: Off-protocol selection increases the risk of unfavorable outcomes
8. 188 - Effect of a decision aid for lower urinary tract symptoms due to benign prostatic hyperplasia on informed and value congruent decision making: A prospective study with a historical control group
9. 1 - Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIME
10. P042 - Dutch practice patterns of active surveillance for prostate cancer: Is there a relationship between protocol adherence and oncological outcomes?
11. O2 - An interim analysis of the FUTURE trial; A RCT on target prostate biopsy based on MR imaging. Comparison of targeted and systematic biopsy outcomes
12. P003A - An interim analysis of the FUTURE trial; A RCT on three techniques of target prostate biopsy based on MR imaging. Comparison of detection rates of (significant) prostate cancer
13. P003B - Clinical predictors of PIRADS≥3 lesions on MP-MRI in patients with negative prior prostate biopsies and a persisting clinical suspicion on prostate cancer
14. P042 Percutaneous X-Per Guided® cryo-ablation of renal masses; oncological results of the largest Dutch series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.